Bybit x FXStreet TradFi Report: Why This Week’s CPI and PPI Data Is a Make-or-Break Event
DUBAI, UAE, Sept. 10, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange…
Upstream Bio to Host Conference Call and Webcast to Report Top-Line Data from the Phase 2 VIBRANT Trial of Verekitug in Patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
WALTHAM, Mass., Sept. 01, 2025 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq:…
Basiz Fund Services achieves compliance with the rigorous ISO 27001 certification
This certification comes after weeks of due diligence and evidence gathering by…
VVDN Expands Manufacturing Footprint into the UAE to Meet Global Demand
GURUGRAM, India, Aug. 20, 2025 /PRNewswire/ -- VVDN Technologies, a global provider…
First-of-Its-Kind Japan Preschool Exchange Lets Global Families Experience Real Japanese School Life — With a Little Help from Peppa Pig
TOKYO, Aug. 5, 2025 /PRNewswire/ -- Japan Preschool Exchange (JPE), a cultural…
Branded Legacy Inc. Announces Leadership Transition and Pending Merger with Innovative Addiction Therapeutics Company Projecting $40 Million in First-Year Revenue
ORLANDO, Fla., July 14, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded…
ASIA’S 50 BEST BARS 2025 REVEALS THE ESTABLISHMENTS RANKED ON THE EXTENDED 51-100 LIST
LONDON, July 3, 2025 /PRNewswire/ -- Casting a spotlight on an expanded…
Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine
Data presented simultaneously at the American Diabetes Association’s® 85th Scientific Sessions, showed…
THE COUNTDOWN IS ON: TWO WEEKS TO GO UNTIL HUBLOT STARTS THE CLOCK ON UEFA WOMEN’S EURO 2025
FOOTBALL COMES TO SWITZERLAND THIS SUMMER WITH THE UEFA WOMEN'S EURO 2025™.…
Celldex Presents Data Demonstrating Profound Long Term Improvement in Angioedemain Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2025
June 14, 2025 10:48 ET | Source: Celldex Therapeutics, Inc. 77% of…